Charles Gill
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 8
- Antifungal resistance and susceptibility 6
- Parasitic Diseases Research and Treatment 2
- Pharmacology 11
- Microbial Natural Products and Biosynthesis 6
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Amy FlatteryGeorge K. AbruzzoHugh RosenMyra B. KurtzKen BartizalJeffrey G. SmithV.B. PikounisLi Kong
- Journals
- The Journal of Antibiotics (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)Journal of Biological Chemistry (2 papers)Journal of the American Chemical Society (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesSpainJapan
In The Last Decade
Charles Gill
22 papers receiving 712 citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 267
- Molecular Medicine 70
- Pharmacology 237
- Applied Microbiology and Biotechnology 15
- Microbiology 41
Countries citing papers authored by Charles Gill
This map shows the geographic impact of Charles Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Gill more than expected).
Fields of papers citing papers by Charles Gill
This network shows the impact of papers produced by Charles Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Gill. The network helps show where Charles Gill may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Gill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2017 | 72 | |
| 3 | 2017 | 1 | |
| 4 | 2016 | 2 | |
| 5 | 2014 | 18 | |
| 6 | 2012 | 52 | |
| 7 | 2011 | 14 | |
| 8 | 2010 | 16 | |
| 9 | 2008 | 48 | |
| 10 | 2007 | 37 | |
| 11 | 2007 | 9 | |
| 12 | 2005 | 2 | |
| 13 | 2003 | 68 | |
| 14 | 2000 | 142 | |
| 15 | 1998 | 97 | |
| 16 | 1998 | 57 | |
| 17 | 1998 | 19 | |
| 18 | 1995 | 6 | |
| 19 | 1989 | 12 | |
| 20 | 1985 | 6 |
About Charles Gill
Charles Gill is a scholar working on Infectious Diseases, Pharmacology, Molecular Medicine, Microbiology and Clinical Biochemistry, having authored 22 papers that have together received 747 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Microbial Natural Products and Biosynthesis (6 papers), Antifungal resistance and susceptibility (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (3 papers), RNA and protein synthesis mechanisms (3 papers), Parasitic Diseases Research and Treatment (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Infectious Diseases (267 citations), Molecular Medicine (70 citations), Pharmacology (237 citations), Applied Microbiology and Biotechnology (15 citations) and Microbiology (41 citations). Charles Gill has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Amy Flattery, George K. Abruzzo, Hugh Rosen, Myra B. Kurtz, Ken Bartizal, Jeffrey G. Smith, V.B. Pikounis, Li Kong, Jesse J. Jackson and Mark Rosenbach. Their work appears in journals such as The Journal of Antibiotics, Antimicrobial Agents and Chemotherapy, Journal of Biological Chemistry, Journal of the American Chemical Society and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.